TISLELIZUMAB-JSGR for Diffuse large b-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where TISLELIZUMAB-JSGR was used for Diffuse large b-cell lymphoma.
Most Reported Side Effects for TISLELIZUMAB-JSGR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 15 | 30.0% | 2 | 0 |
| Off label use | 9 | 18.0% | 2 | 1 |
| Anaemia | 8 | 16.0% | 1 | 1 |
| Pneumonia | 8 | 16.0% | 2 | 7 |
| Lymphadenopathy | 7 | 14.0% | 0 | 0 |
| Thrombocytopenia | 7 | 14.0% | 0 | 0 |
| Infusion related reaction | 6 | 12.0% | 0 | 6 |
| Pyrexia | 6 | 12.0% | 0 | 5 |
| Death | 5 | 10.0% | 5 | 0 |
Other Indications for TISLELIZUMAB-JSGR
Oesophageal adenocarcinoma (13)
Oesophageal squamous cell carcinoma (11)
Product used for unknown indication (10)
Richter's syndrome (9)
Chronic lymphocytic leukaemia (8)
Gastrooesophageal reflux disease (6)
Prophylaxis (6)
Other Drugs Used for Diffuse large b-cell lymphoma
RITUXIMAB (22,275)
CYCLOPHOSPHAMIDE (16,598)
DOXORUBICIN (15,213)
VINCRISTINE (14,922)
PREDNISONE (11,266)
LENALIDOMIDE (7,858)
ETOPOSIDE (4,698)
PREDNISOLONE (4,086)
CYTARABINE (3,857)
DEXAMETHASONE (3,696)